PH23660A - Homodisaccharide hypoglycemic agents - Google Patents
Homodisaccharide hypoglycemic agentsInfo
- Publication number
- PH23660A PH23660A PH33204A PH33204A PH23660A PH 23660 A PH23660 A PH 23660A PH 33204 A PH33204 A PH 33204A PH 33204 A PH33204 A PH 33204A PH 23660 A PH23660 A PH 23660A
- Authority
- PH
- Philippines
- Prior art keywords
- homodisaccharide
- hypoglycemic agents
- homonojirimycin
- protected
- inhibitors
- Prior art date
Links
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 229940126904 hypoglycaemic agent Drugs 0.000 title 1
- -1 Homonojirimycin glycosides Chemical class 0.000 abstract 2
- CLVUFWXGNIFGNC-QTSLKERKSA-N (2r,3s,5r,6r)-2,6-bis(hydroxymethyl)piperidine-3,4,5-triol Chemical compound OC[C@H]1N[C@H](CO)[C@H](O)C(O)[C@@H]1O CLVUFWXGNIFGNC-QTSLKERKSA-N 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 102000038379 digestive enzymes Human genes 0.000 abstract 1
- 108091007734 digestive enzymes Proteins 0.000 abstract 1
- 229930182470 glycoside Natural products 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Luminescent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/683,127 US4634765A (en) | 1984-12-18 | 1984-12-18 | Homodisaccharide hypoglycemic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH23660A true PH23660A (en) | 1989-09-27 |
Family
ID=24742682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH33204A PH23660A (en) | 1984-12-18 | 1985-12-18 | Homodisaccharide hypoglycemic agents |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4634765A (OSRAM) |
| EP (1) | EP0186103B1 (OSRAM) |
| JP (1) | JPS61158994A (OSRAM) |
| KR (1) | KR900005607B1 (OSRAM) |
| CN (1) | CN1016784B (OSRAM) |
| AT (1) | ATE62249T1 (OSRAM) |
| AU (1) | AU574246B2 (OSRAM) |
| CA (1) | CA1240989A (OSRAM) |
| DE (1) | DE3582420D1 (OSRAM) |
| DK (1) | DK587085A (OSRAM) |
| ES (1) | ES8706164A1 (OSRAM) |
| FI (1) | FI80707C (OSRAM) |
| GR (1) | GR853032B (OSRAM) |
| HU (1) | HU194263B (OSRAM) |
| IE (1) | IE58186B1 (OSRAM) |
| NO (1) | NO162387B (OSRAM) |
| NZ (1) | NZ214570A (OSRAM) |
| PH (1) | PH23660A (OSRAM) |
| PT (1) | PT81689B (OSRAM) |
| ZA (1) | ZA859573B (OSRAM) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2181729B (en) * | 1985-10-12 | 1990-04-04 | Nippon Shinyaku Co Ltd | Glucosylmoranoline derivatives and production thereof |
| JPS62242692A (ja) * | 1986-04-15 | 1987-10-23 | Nippon Shinyaku Co Ltd | モラノリン誘導体の製造法 |
| EP0345104B1 (en) * | 1988-06-02 | 1995-11-02 | Merrell Dow Pharmaceuticals Inc. | Novel Alpha-glucosidase inhibitors |
| EP0344383A1 (en) * | 1988-06-02 | 1989-12-06 | Merrell Dow Pharmaceuticals Inc. | Novel alpha-Glucosidase inhibitors |
| US4880917A (en) * | 1988-07-01 | 1989-11-14 | Merrell Dow Pharmaceuticals Inc. | Process for hydrolyzing 2,6-dideoxy-2,6-iminoheptononitrile derivatives using trifluoroacetic acid and dinitrogen tetroxide |
| US4908439A (en) * | 1988-09-16 | 1990-03-13 | Merrell Dow Pharmaceuticals Inc. | Synthesis of intermediate useful in the preparation of nojirimycin and related compounds |
| US5227479A (en) * | 1989-12-20 | 1993-07-13 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of nojirimycin and related compounds |
| US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
| KR100891756B1 (ko) * | 1997-04-15 | 2009-04-07 | 씨에스아이알 | 식욕 억제 활성을 갖는 약학 조성물 |
| GB2396815B (en) * | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
| WO2001074776A1 (en) | 2000-03-31 | 2001-10-11 | Michigan State University | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| KR20070084455A (ko) * | 2004-11-23 | 2007-08-24 | 워너-램버트 캄파니 엘엘씨 | 지질혈증 치료용 ｈｍｇ ｃｏ-ａ 환원효소 억제제로서의7-(2ｈ-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체 |
| US7973157B2 (en) * | 2005-06-08 | 2011-07-05 | Amicus Therapeutics, Inc. | Imino and amino sugar purification |
| JP2008545800A (ja) * | 2005-06-08 | 2008-12-18 | アミカス セラピューティックス インコーポレイテッド | トリフラート化化合物の安定化 |
| BRPI0613221A2 (pt) * | 2005-06-08 | 2010-12-28 | Amicus Therapeutics Inc | furanose cristalina e método para produzir uma furanose cristalina |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2094643B1 (en) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| EP2120980B1 (en) | 2007-03-12 | 2011-08-03 | Zadec APS | An anti-diabetic extract of rooibos |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2930674A1 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| JP2013528172A (ja) | 2010-05-21 | 2013-07-08 | ファイザー・インク | ２−フェニルベンゾイルアミド |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN102462726B (zh) * | 2010-11-04 | 2016-03-09 | 中国医学科学院药物研究所 | 白树总生物碱及多羟基生物碱化合物的提取、分离及用途 |
| WO2012120414A2 (en) | 2011-03-04 | 2012-09-13 | Pfizer Inc. | Edn3-like peptides and uses thereof |
| US20140323705A1 (en) * | 2011-05-13 | 2014-10-30 | Markus Hederos | Manufacture of lacto-n-tetraose |
| US20150050371A1 (en) | 2012-03-09 | 2015-02-19 | Biotropics Malaysia Berhad | Extract Formulations of Rhodamnia Cinerea And Uses Thereof |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| HK1220611A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 用於治疗胃肠道病症的组成物 |
| KR101695582B1 (ko) | 2013-04-17 | 2017-01-13 | 화이자 인코포레이티드 | 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체 |
| SI3004138T1 (sl) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Limited | Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo |
| JP6769963B2 (ja) | 2014-08-29 | 2020-10-14 | ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ | α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| CN104530150A (zh) * | 2015-01-14 | 2015-04-22 | 佛山市赛维斯医药科技有限公司 | 含胺基苯和双葡萄糖苷结构化合物、其制备方法和用途 |
| JP2020500838A (ja) | 2016-10-14 | 2020-01-16 | ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ | Α−アミノ−β−カルボキシムコン酸セミアルデヒドデカルボキシラーゼの阻害剤 |
| IT201700078102A1 (it) | 2017-07-11 | 2019-01-11 | Dipharma Francis Srl | Sintesi di un azazucchero e suoi intermedi |
| CN108828121B (zh) * | 2018-06-14 | 2020-06-05 | 华润三九医药股份有限公司 | 一种白树药材中α-高野尻霉素的含量检测方法 |
| MX2021005904A (es) | 2018-11-20 | 2021-09-08 | Tes Pharma S R L | Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa. |
| CN119060040A (zh) | 2019-01-18 | 2024-12-03 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4065562A (en) * | 1975-12-29 | 1977-12-27 | Nippon Shinyaku Co., Ltd. | Method and composition for reducing blood glucose levels |
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| DE2848117A1 (de) * | 1978-11-06 | 1980-05-14 | Bayer Ag | Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels |
| DE2942365A1 (de) * | 1979-10-19 | 1981-05-14 | Bayer Ag, 5090 Leverkusen | 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB2064527B (en) * | 1979-12-08 | 1984-05-02 | Nippon Shinyaku Co Ltd | Moranoline derivatives and process for preparation thereof |
| IT1210476B (it) * | 1981-05-28 | 1989-09-14 | Erba Farmitalia | Antracicline. |
-
1984
- 1984-12-18 US US06/683,127 patent/US4634765A/en not_active Expired - Lifetime
-
1985
- 1985-12-05 AU AU50810/85A patent/AU574246B2/en not_active Ceased
- 1985-12-13 FI FI854944A patent/FI80707C/fi not_active IP Right Cessation
- 1985-12-13 ZA ZA859573A patent/ZA859573B/xx unknown
- 1985-12-13 CA CA000497607A patent/CA1240989A/en not_active Expired
- 1985-12-16 PT PT81689A patent/PT81689B/pt not_active IP Right Cessation
- 1985-12-16 HU HU854804A patent/HU194263B/hu not_active IP Right Cessation
- 1985-12-16 IE IE317985A patent/IE58186B1/en not_active IP Right Cessation
- 1985-12-16 NZ NZ214570A patent/NZ214570A/en unknown
- 1985-12-17 AT AT85116117T patent/ATE62249T1/de not_active IP Right Cessation
- 1985-12-17 JP JP60282167A patent/JPS61158994A/ja active Granted
- 1985-12-17 EP EP85116117A patent/EP0186103B1/en not_active Expired - Lifetime
- 1985-12-17 NO NO855087A patent/NO162387B/no unknown
- 1985-12-17 DE DE8585116117T patent/DE3582420D1/de not_active Expired - Fee Related
- 1985-12-17 CN CN85109548A patent/CN1016784B/zh not_active Expired
- 1985-12-17 ES ES550060A patent/ES8706164A1/es not_active Expired
- 1985-12-17 DK DK587085A patent/DK587085A/da not_active Application Discontinuation
- 1985-12-17 GR GR853032A patent/GR853032B/el unknown
- 1985-12-18 PH PH33204A patent/PH23660A/en unknown
- 1985-12-18 KR KR1019850009529A patent/KR900005607B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA859573B (en) | 1986-08-27 |
| US4634765A (en) | 1987-01-06 |
| PT81689A (en) | 1986-01-01 |
| GR853032B (OSRAM) | 1986-04-18 |
| HUT40137A (en) | 1986-11-28 |
| CA1240989A (en) | 1988-08-23 |
| IE853179L (en) | 1986-06-18 |
| FI80707C (fi) | 1990-07-10 |
| HU194263B (en) | 1988-01-28 |
| ES550060A0 (es) | 1987-06-01 |
| FI854944A0 (fi) | 1985-12-13 |
| CN85109548A (zh) | 1986-07-09 |
| DE3582420D1 (de) | 1991-05-08 |
| KR900005607B1 (ko) | 1990-07-31 |
| IE58186B1 (en) | 1993-07-28 |
| PT81689B (pt) | 1987-11-30 |
| NO855087L (no) | 1986-06-19 |
| JPS61158994A (ja) | 1986-07-18 |
| ATE62249T1 (de) | 1991-04-15 |
| NO162387B (no) | 1989-09-11 |
| AU5081085A (en) | 1986-06-26 |
| FI854944L (fi) | 1986-06-19 |
| FI80707B (fi) | 1990-03-30 |
| KR860004921A (ko) | 1986-07-16 |
| EP0186103B1 (en) | 1991-04-03 |
| JPH0565519B2 (OSRAM) | 1993-09-17 |
| EP0186103A3 (en) | 1988-02-03 |
| DK587085A (da) | 1986-06-19 |
| ES8706164A1 (es) | 1987-06-01 |
| EP0186103A2 (en) | 1986-07-02 |
| AU574246B2 (en) | 1988-06-30 |
| CN1016784B (zh) | 1992-05-27 |
| DK587085D0 (da) | 1985-12-17 |
| NZ214570A (en) | 1988-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0186103A3 (en) | Homodisaccharide hypoglycemic agents | |
| AU575668B2 (en) | N - acylpyrrolidine compound | |
| AU576280B2 (en) | Inhibition of decomposition of hydrogen peroxide systems | |
| AU3755785A (en) | Sodium hypophosphite modified acryic acid copolymers | |
| AU536200B2 (en) | Compound having anthelmintic and acaricidal activities | |
| PL264223A1 (en) | Protected enzymatic system | |
| EP0104047A3 (en) | Modified oligosaccharides used as substrate for measuring alpha-amylase activity | |
| AU574864B2 (en) | Multiple solution intravenous system | |
| AU6675381A (en) | Protection of substrates from microorganisms | |
| DE3563044D1 (en) | Optically active di(3-chlor-2-oxypropyl-trimethyl-ammonium) tartrate | |
| AU5358786A (en) | Active hydrogen containing compositions | |
| AU563995B2 (en) | Hypotriglyceridemically active polysaccharides | |
| AU4477385A (en) | 4h-1,4-benzothiazines as inhibitors/stimulators of enzymatic reactions | |
| AU6523186A (en) | Transfer function generation for active noise cancellation | |
| AU3994085A (en) | Compositions contenant des lipides actifs | |
| EP0114389A3 (en) | Substituted arylglyoxal derivatives | |
| SU1166473A1 (ru) | ДИТИОАЦЕТИЛГИДРАЗОН α -КАМФОРХИНОНА, ПРОЯВЛЯЮЩИЙ ПРОТИВОГИПОКСИЧЕСКУЮ АКТИВНОСТЬ | |
| PL239327A1 (en) | Method of isolation of polyfungine from the culture of highefficient mutant of streptomyces noursei var. polifungini strain | |
| AU2557084A (en) | Production of alpha-amylase inhibitor-tendamistat from streptomyces | |
| GB8417649D0 (en) | Active vibration cancelling mount | |
| CA1266642C (en) | MONOSACCHARIDE COMPOUNDS WITH IMMUNOSTIMULATING ACTION | |
| IE861883L (en) | Enzymes which catalyze the degradation of lignin | |
| AU8315687A (en) | Propagation of seedlings | |
| IT8320426A0 (it) | Composizione di policarbonato autoestinguente. | |
| IT8320903A0 (it) | Composizione di policarbonato autoestinguente. |